OctreoTherTM: Ongoing Early Clinical Development of a Somatostatin-Receptor-Targeted Radionuclide Antineoplastic Therapy

Publisher： Karger

E-ISSN： 1421-9867|62|1|69-72

ISSN： 0012-2823

Source： Digestion, Vol.62, Iss.1, 2000-07, pp. : 69-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs

By Shimon Ilan  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 265-269

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin and somatostatin receptor physiology

By Barnett Philip  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 255-264

Humana Press, Inc

Access to resources Recommend Favorite

Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Somatostatin and Its Receptor Family

By Patel Y.C.  

Frontiers in Neuroendocrinology, Vol. 20, Iss. 3, 1999-07 ,pp. : 157-198

Elsevier

Access to resources Recommend Favorite

Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review

By Fleseriu Maria  

Pituitary, Vol. 14, Iss. 2, 2011-06 ,pp. : 184-193

Springer Publishing Company

Access to resources Recommend Favorite